Lorediplon
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
This is the current revision of this page, as edited by Citation bot (talk | contribs) at 05:28, 28 January 2023 (Alter: chapter-url. URLs might have been anonymized. | Use this bot. Report bugs. | Suggested by Abductive | Category:GABAA receptor positive allosteric modulators | #UCB_Category 313/459). The present address (URL) is a permanent link to this version.
Revision as of 05:28, 28 January 2023 by Citation bot (talk | contribs) (Alter: chapter-url. URLs might have been anonymized. | Use this bot. Report bugs. | Suggested by Abductive | Category:GABAA receptor positive allosteric modulators | #UCB_Category 313/459)
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Chemical compound
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H15FN4O2S |
Molar mass | 394.42 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Lorediplon (INN) is a nonbenzodiazepine of the pyrazolopyrimidine family that is being pursued as a treatment for insomnia but has not completed development.[1][2]
See also
[edit]References
[edit]- ^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN): Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2): 179.
- ^ Misra AK, Sharma PK (2020). "Sedative and Hypnotic Drugs". In Uddin MS, Rashid M (eds.). Advances in Neuropharmacology: Drugs and Therapeutics. New York: Apple Academic Press. p. 441. ISBN 978-0-429-51589-7.
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents | |
Monoureides | |
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|